Most Popular in:
New in Regulatory (page 7 of 13)
Apr 19, 2012 | 04:03 PM CDT
The Personal Care Product's Council and the Safe Cosmetics Alliance have both announced their support for H.R. 4395, a bill introduced by Representative Leonard Lance known as the "Cosmetic Safety Amendments Act of 2012.
Apr 04, 2012 | 03:45 PM CDT
By: Darrin C. Duber-Smith and Gregory Black
The beauty industry is hypercompetitive, and on-shelf success requires that new product development is conducted as scientifically as possible, utilizing proven models and due diligence.
Mar 20, 2012 | 04:24 PM CDT
By: Giles Chappell
In a preview of his InnoCos Europe presentation, Giles Chappell offers some insights into how EU regulations will impact nanomaterials.
Mar 13, 2012 | 11:18 AM CDT
The Personal Care Products Council (PCPC) has responded to a study by the Silent Spring Institute that claims to have found harmful chemicals in a variety of beauty care and household products.
Mar 13, 2012 | 07:48 AM CDT
L’Oréal and the U.S. Environmental Protection Agency (EPA) announce research collaboration to develop animal-alternative toxicity tests; L’Oréal providing the EPA $1.2 million in funding in addition to safety data.
Feb 20, 2012 | 08:33 AM CST
The Personal Care Product's Council (PCPC) has released a statement in response to the December 2011 study on lead in lipsticks conducted by the U.S. Food and Drug Administration (FDA).
Jan 31, 2012 | 11:07 AM CST
By: Claire Thévenin
Ingredients, claims and endocrine disruptors were some of the many subjects discussed at the ninth edition of Cosmetic Valley’s Congrès Parfums & Cosmétiques on regulatory issues, held in Chartres, France, in November.
Jan 31, 2012 | 08:40 AM CST
New name for the 50 year-old European association designed to reflect the viability and leading role of European beauty industry globally.
Jan 13, 2012 | 01:09 PM CST
The webinar will take place on Jan. 18, 2012.
Nov 29, 2011 | 11:28 AM CST
By: Ada Polla and Anne Pouillot
A number of ingredients have been vilified, and ingredient myths have perpetuated. Scientific evidence suggests that some should be eliminated from formulations; the use of others, while safe according to the available scientific data, should be considered for commercial reasons related to consumer perception.